Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection [Phase 4]
A completed Phase 4 clinical trial evaluating somatostatin for advanced gastric cancer after D2 lymph node dissection.
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Perioperative Application of Omega-3 Polyunsaturated Fatty Acids in Gastric Cancer Patients [Phase 4]
This document provides a status update on a Phase 4 trial evaluating perioperative omega-3 fatty acids in gastric cancer patients.
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach [Phase 2]
A Radiation Therapy Oncology Group Phase 2 trial evaluating combination chemotherapy plus radiation therapy, with or without fluorouracil, i…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: T900607 in Treating Patients With Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial update for the agent T900607 in patients with gastric cancer and gastroesophageal junction cancer; the study status i…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial [Phase 3]
A Phase 3 randomized trial comparing gastrectomy with metastasectomy plus systemic therapy against systemic therapy alone in gastric cancer …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin [Phase 2]
Phase 2 trial evaluating weekly docetaxel plus irinotecan in patients with non-resectable gastric cancer after cisplatin plus 5-FU/leucovori…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer [Phase 2]
Phase 2 clinical trial update on a combination chemotherapy regimen given before and after gastrectomy for gastric cancer, with the study st…
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating cetuximab with paclitaxel, carboplatin, and radiation for esophageal and gastric cancers has completed wit…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer [Phase 1]
This completed Phase 1 trial evaluated a combination of vorinostat, irinotecan, fluorouracil, and leucovorin in patients with advanced upper…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer [Phase 2]
A multicenter Phase II study evaluating neoadjuvant docetaxel, cisplatin, and capecitabine with protocolized surgery for resectable gastric …
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer [Phase 2]
This update reports the completion of a Phase 2 trial evaluating the TEX combination (docetaxel, oxaliplatin, capecitabine) for advanced or …
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer [Phase 1]
Phase 1 trial results for the combination of oxaliplatin and irinotecan in patients with metastatic gastrointestinal cancers, including anal…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer [Phase 3]
A Phase 3 trial evaluating S-1 plus cisplatin in patients undergoing surgery for stage III gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial updates on erlotinib for locally advanced or metastatic stomach cancer and gastroesophageal junction cancer.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer [Phase 1]
Phase 1 clinical trial update evaluating chemotherapy in patients with refractory advanced solid tumors or hematologic cancers across multip…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer [Phase 2]
Phase 2 clinical trial comparing different combination chemotherapy regimens for advanced gastric cancer. The study aims to evaluate the reg…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer [Phase 2]
A Phase 2 clinical trial evaluating cisplatin and irinotecan in locally advanced or metastatic esophageal or gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas [Phase 1]
Phase 1 study of the BMS-833923 investigational agent in combination with cisplatin and capecitabine in patients with inoperable, metastatic…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer [Phase 2]
Phase 2 study evaluating Bryostatin 1 in combination with Paclitaxel for locally advanced or metastatic esophageal or gastric cancer; the tr…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer [Phase 2]
This Phase 2 trial evaluated a sequence of combination chemotherapy, followed by surgery and intraperitoneal chemotherapy, for locally advan…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer [Phase 1]
Phase 1 clinical trial evaluating the safety and feasibility of combining chemotherapy with radiation therapy for esophageal cancer (also in…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy [Phase 2]
A Phase 2 trial evaluating BMS-247550 in patients with recurrent metastatic gastric cancer previously treated with chemotherapy has complete…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer [Phase 3]
Phase 3 feasibility study evaluating adjuvant chemoradiotherapy for gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer [Phase 2]
Phase 2 study evaluating trastuzumab in combination with TS-ONE and cisplatin as first-line therapy for HER2-positive advanced gastric cance…
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT [Phase 1, Phase 2]
A terminated Phase I/II randomized trial evaluated neoadjuvant chemoradiotherapy with S-1 and radiotherapy vs. S-1 plus oxaliplatin and radi…